Want to see HK:1672 full AI Analyst Report?
Ascletis Pharma, Inc. (1672) Ownership - Who Owns Ascletis Pharma, Inc.?
9 Followers
Ascletis Pharma, Inc. (1672) Ownership Overview
- 0.12% Mutual Funds
- 0.68% ETFs
- 99.21% Public Companies and Individual Investors
The ownership structure of Ascletis Pharma, Inc. (HK:1672) stock is a mix of institutional, retail, and individual investors. Approximately 0.79% of the company’s stock is owned by Institutional Investors, and 99.21% is owned by Public Companies and Individual Investors.
The ownership structure of Ascletis Pharma, Inc. (HK:1672) stock is a mix of institutional, retail, and individual investors. Approximately 0.79% of the company’s stock is owned by Institutional Investors, and 99.21% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 3,769,000 | Institution | 0.36% | 2,189,789 |
| Roundhill | 2,327,000 | Institution | 0.22% | 1,351,987 |
| State Street | 916,000 | Institution | 0.09% | 532,196 |
| Dfa Investment Dimensions Group Inc | 799,000 | Institution | 0.08% | 464,219 |
| Fidelity Salem Street Trust | 216,000 | Institution | 0.02% | 125,496 |
| Ab Cap Fund, Inc. | 203,000 | Institution | 0.02% | 117,943 |
| Spdr | 120,000 | Institution | 0.01% | 69,720 |
| Avantis | 40,000 | Institution | <0.01% | 23,240 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Dfa Investment Dimensions Group Inc | 799,000 | Institution | 0.08% | 464,219 |
| Fidelity Salem Street Trust | 216,000 | Institution | 0.02% | 125,496 |
| Ab Cap Fund, Inc. | 203,000 | Institution | 0.02% | 117,943 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Roundhill, OZEM ETF | 2,327,000 | Institution | 0.22% | 1,278,286 |
| iShares, IEMG ETF | 2,085,000 | Institution | 0.20% | 1,234,370 |
| State Street, SPEM ETF | 714,000 | Institution | 0.07% | 392,220 |
| State Street, EWX ETF | 160,000 | Institution | 0.02% | 87,892 |
| SPDR, GB:EMSM ETF | 108,000 | Institution | 0.01% | 59,327 |
| iShares, ECNS ETF | 91,000 | Institution | <0.01% | 53,874 |
| iShares, TSE:XEC ETF | 73,000 | Institution | <0.01% | 61,781 |
| iShares, TSE:XEC.U ETF | 73,000 | Institution | <0.01% | 61,781 |
| iShares, EEMS ETF | 58,000 | Institution | <0.01% | 34,337 |
| Avantis, AVSE ETF | 40,000 | Institution | <0.01% | 21,920 |
FAQ
What percentage of Ascletis Pharma, Inc. (HK:1672) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.79% of Ascletis Pharma, Inc. (HK:1672) stock is held by institutional investors: 0.12% by mutual funds and 0.68% by ETFs.
What percentage of Ascletis Pharma, Inc. (HK:1672) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.21% of Ascletis Pharma, Inc. (HK:1672) stock is held by public companies and individual investors.
Who owns the most shares of Ascletis Pharma, Inc. (HK:1672)?
iShares owns the most shares of Ascletis Pharma, Inc. (HK:1672).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
